These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35674931)

  • 1. Valproic Acid-Induced Anxiety and Depression Behaviors are Ameliorated in p39 Cdk5 Activator-Deficient Mice.
    Takahashi M; Takasugi T; Kawakami A; Wei R; Ando K; Ohshima T; Hisanaga SI
    Neurochem Res; 2022 Sep; 47(9):2773-2779. PubMed ID: 35674931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
    J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
    Bankston AN; Li W; Zhang H; Ku L; Liu G; Papa F; Zhao L; Bibb JA; Cambi F; Tiwari-Woodruff SK; Feng Y
    J Biol Chem; 2013 Jun; 288(25):18047-57. PubMed ID: 23645679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.
    Saito T; Yano M; Kawai Y; Asada A; Wada M; Doi H; Hisanaga SI
    J Biol Chem; 2013 Nov; 288(45):32433-32439. PubMed ID: 24085300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.
    Luo F; Zhang J; Burke K; Miller RH; Yang Y
    J Neurosci; 2016 Mar; 36(10):3024-37. PubMed ID: 26961956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA.
    Takahashi M; Ishida M; Saito T; Ohshima T; Hisanaga S
    Biochem Biophys Res Commun; 2014 May; 447(4):678-82. PubMed ID: 24755075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.
    Ko J; Humbert S; Bronson RT; Takahashi S; Kulkarni AB; Li E; Tsai LH
    J Neurosci; 2001 Sep; 21(17):6758-71. PubMed ID: 11517264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.
    Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI
    J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral and orofacial pain sensation is unaffected by the loss of p39.
    Prochazkova M; Hall B; Hu M; Okine T; Reukauf J; Binukumar BK; Amin ND; Roque E; Pant HC; Kulkarni A
    Mol Pain; 2017; 13():1744806917737205. PubMed ID: 28969475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
    Asada A; Saito T; Hisanaga S
    J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
    Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
    J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.
    Ito Y; Asada A; Kobayashi H; Takano T; Sharma G; Saito T; Ohta Y; Amano M; Kaibuchi K; Hisanaga S
    Mol Cell Neurosci; 2014 Jul; 61():34-45. PubMed ID: 24877974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid increases NO production via the SH-PTP1-CDK5-eNOS-Ser(116) signaling cascade in endothelial cells and mice.
    Cho DH; Park JH; Joo Lee E; Jong Won K; Lee SH; Kim YH; Hwang S; Ja Kwon K; Young Shin C; Song KH; Jo I; Han SH
    Free Radic Biol Med; 2014 Nov; 76():96-106. PubMed ID: 25150199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p39-associated Cdk5 activity regulates dendritic morphogenesis.
    Ouyang L; Chen Y; Wang Y; Chen Y; Fu AKY; Fu WY; Ip NY
    Sci Rep; 2020 Oct; 10(1):18746. PubMed ID: 33127972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.
    Johansson JU; Lilja L; Chen XL; Higashida H; Meister B; Noda M; Zhong ZG; Yokoyama S; Berggren PO; Bark C
    Brain Res Mol Brain Res; 2005 Aug; 138(2):215-27. PubMed ID: 15908038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
    Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
    J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton.
    Humbert S; Dhavan R; Tsai L
    J Cell Sci; 2000 Mar; 113 ( Pt 6)():975-83. PubMed ID: 10683146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules.
    Takahashi S; Saito T; Hisanaga S; Pant HC; Kulkarni AB
    J Biol Chem; 2003 Mar; 278(12):10506-15. PubMed ID: 12536148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cyclin-dependent kinase 5 activator, p39, is expressed in stripes in the mouse cerebellum.
    Jeong YG; Rosales JL; Marzban H; Sillitoe RV; Park DG; Hawkes R; Lee KY
    Neuroscience; 2003; 118(2):323-34. PubMed ID: 12699769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.